The work of the Stanley Laboratory is at the intersection of three areas:
New tools for remote neural modulation
We are pioneering the use of static and alternating magnetic fields to regulate the activity of individual cells and neurons – a technique that, like optogenetics, has broad research and therapeutic applications but which is non-invasive. We are extending theses tools to target specific neural populations.
We are using synthetic and naturally occurring biological nanoparticles to regulate cell activity using different modalities and developing murine models for preclinical applications.
Neuroendocrinology of diabetes
Using the tools we have developed, alongside existing techniques, we are investigating how central and peripheral systems sense and regulate glucose metabolism to find new approaches to diabetes prevention and treatment.
We are fortunate to work in close collaboration with colleagues across Mount Sinai and in partnerships with Professor Jeffrey Friedman, Rockefeller University, and Professor Jonathan Dordick, Rensselaer Polytechnic Institute. Currently, our work is funded by The National Institutes of Health and American Diabetes Association.